BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22935684)

  • 1. [Breast cancer screening: current status].
    Mellado Rodríguez M; Osa Labrador AM
    Radiologia; 2013; 55(4):305-14. PubMed ID: 22935684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European advocacy perspective on mammography screening.
    Knox S
    Breast; 2011 Feb; 20(1):93-5. PubMed ID: 20708405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
    Bell RJ
    Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Canadian study of mammography screening and mortality from breast cancer.
    Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening: why, when, and how many?
    Gemignani ML
    Clin Obstet Gynecol; 2011 Mar; 54(1):125-32. PubMed ID: 21278511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
    Morrell S; Taylor R; Roder D; Dobson A
    J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer early detection methods for low and middle income countries, a review of the evidence.
    Corbex M; Burton R; Sancho-Garnier H
    Breast; 2012 Aug; 21(4):428-34. PubMed ID: 22289154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for high quality mammography screening.
    Matveeva N; Korneti K; Antevska S; Strateska A
    Prilozi; 2008 Dec; 29(2):345-54. PubMed ID: 19259058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group.
    O'Higgins N; Linos DA; Blichert-Toft M; Cataliotti L; de Wolf C; Rochard F; Rutgers EJ; Roberts PJ; Mattheiem W; da Silva MA; Holmberg L; Schulz KD; Smola MG; Mansel RE
    Ann Chir Gynaecol; 1998; 87(1):110-2. PubMed ID: 9598249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How effective are breast cancer screening programmes by mammography? Review of the current evidence.
    Schopper D; de Wolf C
    Eur J Cancer; 2009 Jul; 45(11):1916-23. PubMed ID: 19398327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
    Matkowski R; Szynglarewicz B
    Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients.
    Le-Petross HT; Shetty MK
    Semin Ultrasound CT MR; 2011 Aug; 32(4):266-72. PubMed ID: 21782116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
    Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
    BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Population-based breast cancer screening: certainties, controversies, and future perspectives].
    Apesteguía Ciriza L; Pina Insausti LJ
    Radiologia; 2014; 56(6):479-84. PubMed ID: 24094442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pivotal role for the general practitioner in a mixed mammographic screening model.
    François G; Van Roosbroeck S; Hoeck S; Markovskaia E; Van Hal G
    Rev Epidemiol Sante Publique; 2012 Apr; 60(2):150-6. PubMed ID: 22424750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.